ADC binds HER3 on target cells, is internalized, linker is cleaved to release the DXd topoisomerase I inhibitor; DXd stabilizes the Topo I–DNA cleavage complex causing DNA damage, replication arrest, and apoptosis, with a membrane-permeable payload enabling a bystander effect.